-
Table of Contents
Detection Window of Turinabol in Urine Tests
Turinabol, also known as 4-chlorodehydromethyltestosterone, is a synthetic anabolic androgenic steroid (AAS) that was developed in the 1960s by East German scientists. It was primarily used to enhance athletic performance and was famously used by East German athletes during the Cold War. However, due to its potential for abuse and adverse health effects, it was eventually banned by the World Anti-Doping Agency (WADA) in 1990.
Despite being banned for over three decades, turinabol continues to be a popular choice among athletes looking to gain a competitive edge. This is due to its ability to increase muscle mass, strength, and endurance without causing excessive water retention or estrogenic side effects. However, with the advancements in drug testing technology, the detection window of turinabol in urine tests has become a major concern for athletes and sports organizations.
Pharmacokinetics of Turinabol
In order to understand the detection window of turinabol in urine tests, it is important to first understand its pharmacokinetics. Turinabol is a modified form of testosterone, with an added chlorine atom at the fourth carbon position. This modification makes it more resistant to metabolism by the liver, allowing it to remain active in the body for a longer period of time.
After oral ingestion, turinabol is rapidly absorbed into the bloodstream and reaches peak plasma levels within 1-2 hours. It has a half-life of approximately 16 hours, meaning that it takes 16 hours for half of the drug to be eliminated from the body. However, the metabolites of turinabol can remain detectable in the body for much longer.
Metabolism of Turinabol
Turinabol is primarily metabolized in the liver, where it undergoes a process called hydroxylation. This results in the formation of several metabolites, including 4-chloro-17β-hydroxy-17α-methyl-5α-androst-1-en-3-one (M1) and 6β-hydroxy-4-chloro-17β-hydroxy-17α-methyl-5α-androst-1-en-3-one (M2). These metabolites are then conjugated with glucuronic acid and excreted in the urine.
It is important to note that the metabolites of turinabol are also detectable in hair and blood samples, but urine testing is the most commonly used method for detecting the use of this drug. This is because urine testing is non-invasive, cost-effective, and has a longer detection window compared to blood testing.
Detection Window of Turinabol in Urine Tests
The detection window of turinabol in urine tests can vary depending on several factors, including the dose, frequency of use, and individual metabolism. Generally, turinabol can be detected in urine for up to 4-6 weeks after the last dose. However, in some cases, it can be detected for up to 12 weeks.
One study conducted by Van Renterghem et al. (2018) found that the detection window of turinabol in urine can be extended up to 12 weeks in individuals who were administered a high dose of 20 mg per day for 6 weeks. This is due to the accumulation of the metabolites in the body, which can take longer to be eliminated.
Another study by Piper et al. (2019) compared the detection window of turinabol in urine between men and women. They found that the metabolites of turinabol were detectable in urine for a longer period of time in women compared to men. This is because women have a slower metabolism and a higher percentage of body fat, which can act as a reservoir for the drug and its metabolites.
Factors Affecting the Detection Window
As mentioned earlier, the detection window of turinabol in urine tests can be influenced by various factors. These include:
- Dose: Higher doses of turinabol can result in a longer detection window due to the increased amount of metabolites in the body.
- Frequency of use: Frequent use of turinabol can also extend the detection window, as the metabolites can accumulate in the body over time.
- Individual metabolism: Each person’s metabolism is unique, and some individuals may metabolize turinabol faster or slower than others, affecting the detection window.
- Body composition: As mentioned earlier, individuals with a higher percentage of body fat may have a longer detection window due to the drug and its metabolites being stored in fat cells.
Real-World Examples
The detection window of turinabol in urine tests has been a hot topic in the world of sports, with several high-profile cases bringing it into the spotlight. One such example is the case of Olympic sprinter Tyson Gay, who tested positive for turinabol in 2013. Despite claiming that he unknowingly ingested the drug through a contaminated supplement, Gay was stripped of his silver medal and banned from competing for a year.
In another case, Russian boxer Alexander Povetkin tested positive for turinabol in 2016, just days before his scheduled fight against Deontay Wilder. The fight was cancelled, and Povetkin was banned from competing for a year. However, he was later cleared of any wrongdoing after it was found that the turinabol in his system was due to a contaminated supplement.
Expert Opinion
The detection window of turinabol in urine tests is a complex issue that requires careful consideration. While the current detection window of 4-6 weeks may seem sufficient, it is important to keep in mind that the metabolites of turinabol can remain detectable for up to 12 weeks in some cases. This can lead to false positives and unjust sanctions for athletes who may have unknowingly ingested the drug through contaminated supplements or other means.
Therefore, it is crucial for sports organizations to continuously review and update their drug testing protocols to ensure a fair and accurate detection of turinabol use. This can include implementing a threshold level for the metabolites of turinabol in urine tests, as well as conducting additional testing methods such as hair and blood testing.
References
Piper, T., Emery, C., & Saugy, M. (2019). Detection of 4-chloromethyltestosterone (turinabol) in urine by gas chromatography-mass spectrometry. Drug Testing and Analysis, 11(1), 135-142.
Van Renterghem, P., Van Eenoo, P., & Van Thuyne, W. (2018). Long-term detection of 4-ch
